Sat, 21 Nov, 2026☀ Indore 26°C
Market closedSENSEX83,919.71▲ 2.30%NIFTY 5025,800.60▲ 2.27%BANK NIFTY64,635.20▲ 4.19%INDIA VIX17.32▲ 11.24%हिंदी में पढ़ें →All markets →
Stories
BUSINESS1 MIN READ

Modicare Launches ShiftLife Anti-Spike Daily Supplement in India Featuring Reducose

Modicare has launched ShiftLife Anti-Spike Daily in New Delhi, introducing a nutraceutical containing Reducose white mulberry leaf extract to target post-meal glucose spikes.

60-SECOND SUMMARY · AI-ASSISTED
  • Modicare launched ShiftLife Anti-Spike Daily in New Delhi.
  • The product contains 250 mg of Reducose and chromium picolinate.
  • Reducose has shown up to 40% smaller post-meal glucose spikes under specific study conditions.
Pink dress with embroidery, detail, Crafts Museum, New Delhi, India.
हिन्दी में पढ़ेंAI translation · may contain errors
🧒 Explain it simplyAI-written · same facts

Modicare Limited has launched a new nutraceutical product called ShiftLife Anti-Spike Daily in New Delhi. The launch introduces patented British nutritional science to the Indian market, utilizing a white mulberry leaf extract known as Reducose in collaboration with Phynova.

Product Composition and Mechanism

Each serving of ShiftLife Anti-Spike Daily contains 250 mg of Reducose alongside chromium picolinate, which supplies chromium to support normal glucose metabolism. According to clinical study conditions cited by the companies, the Reducose technology has demonstrated reductions of up to 40 percent in post-meal glucose spikes. The formulation aims to moderate the body's insulin response following carbohydrate-rich meals.

Leadership Statements

Dr. Samir Kumar Modi, Founder and Managing Director of Modicare Limited, stated that the product allows individuals to manage post-meal health without abandoning traditional foods. Wouter Claerhout, Vice President of APAC at Phynova, expressed enthusiasm for partnering to make the patented technology accessible to Indian households for everyday metabolic wellness.

Regulatory and Usage Information

The companies noted that ShiftLife Anti-Spike Daily is classified as a nutraceutical rather than a treatment, cure, or prevention for any disease. Certain claims regarding hunger, fullness, cravings, and energy require FSSAI compliance and applicable substantiation. Consumers are advised to follow product labels and consult healthcare professionals.

Key takeaways
  • Modicare introduced ShiftLife Anti-Spike Daily in New Delhi.
  • The supplement features 250 mg of Reducose and chromium picolinate.
  • Makers state the formula is designed to moderate post-meal glucose and insulin responses.
How does this make you feel?
What is your view on this story?
Sign in to vote and see what other readers think.
The Times Reading dailyTop stories, markets and weather in one short email. Free, one-click unsubscribe.

Spotted an error? · Our editorial policy

UP NEXTSanjay Kapoor Stars in ‘Unexpected – Safed Sach’ Based on 2024 Dehradun CaseSwipe more stories · BusinessQuick cards, a few lines each. Tap to open.

More from Business